Clinical Trial Update: A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the potential drug interaction between valproic acid and paliperidone extended-release in adults with schizophrenia, bipolar I disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Bipolar Disorder | Phase 1 | Status: COMPLETED